1. The document discusses the anatomy, physiology, and pharmacology of the autonomic nervous system as it relates to pupil function and abnormalities.
2. Key topics covered include the causes, features, and approaches to evaluating anisocoria, Horner's syndrome, Adie's tonic pupil, and other pupil abnormalities.
3. Tests involving pharmacological agents are described that can help localize lesions in various parts of the autonomic nervous system pathways controlling the pupil.
This document discusses neuro-ophthalmology and optic neuropathies. It begins by outlining the sites of potential lesions in the visual pathway, including the optic nerve, chiasm, and ocular motor nerves. It then covers the various etiologies of optic neuropathies such as inflammatory, ischemic, toxic, nutritional, hereditary, congenital, infiltrative and compressive causes. Specific conditions discussed in more detail include optic neuritis, anterior and posterior ischemic optic neuropathy, papilledema, pseudotumor cerebri and optic atrophy. For each condition, the document outlines clinical presentation, investigations, treatment and prognosis.
This document summarizes the clinical classification and investigations for uveitis. It divides uveitis into infectious and non-infectious categories. Infectious uveitis can be bacterial, viral, fungal or parasitic in origin. Non-infectious uveitis is further divided into those with a known systemic association and those without. Investigations may include blood tests, imaging like ultrasound and angiography, aqueous or vitreous taps, and biopsies depending on the severity, recurrence and presence of granulomatous signs. Specific tests are aimed at identifying underlying infectious or inflammatory diseases. A thorough history and examination provide important clues to guide appropriate investigations.
The document discusses various types of corneal diseases including congenital, traumatic, inflammatory, degenerative/dystrophic, and neoplastic conditions. It provides details on infectious keratitis caused by bacteria like Staphylococcus, Pseudomonas, and Neisseria as well as fungi and protozoa. Viral keratitis from herpes simplex virus, herpes zoster virus, and adenovirus are also examined. Signs, risk factors, investigations, and treatment approaches are described for each condition. Inflammatory keratitis can be infective or immune-related disorders like marginal keratitis and Mooren's ulcer are also reviewed.
A 19-year-old man presented with floaters and vision loss in his left eye over the past year. On examination, he had cells in his anterior chamber, vitreous hemorrhage, a swollen optic disc, cystoid macular edema, subretinal fibrosis, and chorioretinal scars in his left eye. Investigations did not reveal an infectious cause. He was treated with orbital floor triamcinolone injections which improved his cystoid macular edema but caused steroid-induced glaucoma, requiring glaucoma medication. His inflammation later flared up again requiring additional steroid treatment.
This document discusses uveitis, including its classification, description, causes, and clinical presentation. It provides details on:
1) The anatomical, pathological, and clinical classifications of uveitis including anterior, intermediate, posterior, and panuveitis.
2) The description of uveitis including its course (acute, recurrent, relapse, remission), duration (limited, persistent), and onset (sudden, insidious).
3) The common causes of different types of uveitis including infectious (viral, bacterial, fungal, parasitic) and non-infectious etiologies with and without systemic associations. Specific causes of anterior, intermediate, and posterior uveitis are
Uveitis is a general term for intraocular inflammation that does not indicate the specific site or cause of inflammation. It can be caused by autoimmune or infectious processes. Uveitis is a common cause of visual impairment and blindness worldwide. It is classified based on the site of inflammation - anterior, intermediate, posterior or panuveitis. Developing a differential diagnosis involves considering factors such as acuity of onset, laterality, associated symptoms and response to previous therapies. Common etiologies include idiopathic disease, infections like tuberculosis, and autoimmune diseases like sarcoidosis and Behcet's disease. Treatment involves corticosteroids and immunosuppressive therapies.
This document provides information on uveitis, including:
- Epidemiology data showing it is the third leading cause of blindness in developed countries, with highest rates in those over 65.
- Classification systems for uveitis based on location (anterior, intermediate, posterior, panuveitis) and duration (acute vs chronic).
- Signs and symptoms include redness, pain, photophobia, blurry vision, and floaters. Clinical signs depend on location and can include cells in the anterior chamber or snowballs in the vitreous.
- Differential diagnoses and specific types of non-infectious uveitis are discussed, including associations with autoimmune diseases like anky
This document provides an overview of the approach to diagnosing and treating posterior uveitis. It discusses the importance of a thorough clinical assessment to narrow the differential diagnosis and guide diagnostic testing. Common causes of posterior uveitis include infectious diseases like tuberculosis, toxoplasmosis, and viral infections, as well as non-infectious conditions like Behcet's disease, sarcoidosis, and VKH syndrome. Standard diagnostic tests include bloodwork, chest x-ray, fluorescein angiography, and OCT. Targeted testing depends on clinical features and may include vitreous biopsy and serologic testing. Characterization of the uveitis based on features like laterality, site of inflammation, and morphology
This document discusses various infectious causes of uveitis, including viruses, fungi, protozoa, helminths, and bacteria. It covers specific infectious etiologies such as herpesviridae family members, toxoplasmosis, toxocariasis, syphilis, Lyme disease, tuberculosis, and endogenous infectious endophthalmitis. For each condition, it describes clinical features, diagnostic testing, treatment approaches, and prognosis. Infectious uveitis remains an important consideration in uveitis evaluation and management.
This document provides information on diagnosing and treating various types of infective keratitis. It begins by emphasizing the importance of systematically describing any corneal lesion and differentiating infectious keratitis based on history and examination. The main types of infective keratitis discussed are bacterial, viral, fungal, amoebic, and non-infectious keratitis. For each type, the document describes distinguishing examination findings, investigations, and treatment approaches. It provides details on herpes simplex virus keratitis, including its various clinical manifestations and recommendations for long-term antiviral prophylaxis. The document also compares treatment for bacterial versus fungal versus amoebic keratitis. Throughout, it emphasizes the significance of early diagnosis
This document discusses different types of keratitis, including the differences between infective and non-infective keratitis. Non-infective keratitis includes marginal keratitis, phlyctenular keratitis, rosacea, peripheral ulcerative keratitis (PUK), Mooren's ulcer, and interstitial keratitis. PUK is associated with autoimmune diseases like rheumatoid arthritis. Mooren's ulcer presents as a peripheral, circumferential ulcer. Interstitial keratitis can be immune-mediated or infectious in etiology. The document provides details on clinical presentations, investigations, and treatments for different types of non-infective keratitis.
This document discusses various types of primary and secondary glaucomas including:
- Primary open angle glaucoma (POAG) which presents with increased intraocular pressure (IOP) and optic nerve damage in older patients.
- Primary angle closure glaucoma (PACG) which occurs when the iris blocks the drainage angle, commonly in East Asian populations.
- Normal tension glaucoma (NTG) which has optic nerve damage and visual field loss with normal IOP, often associated with nocturnal hypotension.
- Secondary glaucomas caused by conditions like pseudoexfoliation syndrome, pigment dispersion syndrome, neovascular glaucoma, and lens-induced glaucomas
This document summarizes a presentation on various eye conditions. It begins with a case of a 55-year-old woman with headache and blurry vision who is diagnosed with glaucoma. It then discusses the types, risk factors, examination, and management of glaucoma. It also covers hyphema, iritis, endophthalmitis, and compares the features of various red eye conditions like conjunctivitis. Interesting facts about eye anatomy and conditions are provided throughout.
This document summarizes different types of posterior uveitis and retinal vasculitis, including their causes, signs, symptoms, investigations, and treatment. It discusses various white dot syndromes such as multifocal choroiditis, birdshot choroidopathy, and acute macular neuroretinitis. It also covers specific conditions like toxoplasmosis, tuberculosis, frosted branch angiitis, and viral retinitis. Treatment often involves corticosteroids, immunosuppressants, antivirals, and laser photocoagulation depending on the underlying etiology.
This document discusses intermediate uveitis (IU), which involves inflammation in the anterior vitreous, pars plana, and peripheral retina. IU accounts for 8-22% of uveitis cases. Clinically, it is characterized by "snowballs" or yellow-white exudates in the peripheral vitreous. Treatment involves topical/periocular steroids initially, with cryotherapy, vitrectomy or immunosuppressants for non-responsive cases. Complications include cystoid macular edema, cataracts, glaucoma, and retinal detachment. Proper diagnosis requires excluding other causes like syphilis, Lyme disease, multiple sclerosis and sarcoidosis.
ACUTE AND CHRONIC CONDITION OF PHARYNX & LARYNX.pptDrBPSah
This document provides information about pharyngitis (inflammation of the pharynx). It discusses the different causes of pharyngitis including bacterial (e.g. Streptococcus pyogenes), viral (e.g. rhinovirus), and fungal. It provides details on symptoms, diagnosis, treatment, and complications of various types of pharyngitis. It also discusses other conditions that can cause pharyngeal inflammation like diphtheria, tuberculosis, and mononucleosis.
This document provides information about immunization and vaccine-preventable diseases. It discusses:
1. Immunization is a process that uses vaccines to stimulate immunity against infectious diseases. It has proven effective at controlling and eliminating diseases like smallpox.
2. Major vaccine-preventable diseases that kill children include measles, polio, pertussis, Hib, and pneumococcal diseases. Immunization is one of the most cost-effective health interventions.
3. The document then provides details on specific diseases like pertussis, its symptoms, complications, and treatment with antibiotics or immunization. It emphasizes the importance of clinical diagnosis and avoiding severe outcomes in infants.
1. The document discusses the anatomy, physiology, and pharmacology of the autonomic nervous system as it relates to pupil function and abnormalities.
2. Key topics covered include the causes, features, and approaches to evaluating anisocoria, Horner's syndrome, Adie's tonic pupil, and other pupil abnormalities.
3. Tests involving pharmacological agents are described that can help localize lesions in various parts of the autonomic nervous system pathways controlling the pupil.
This document discusses neuro-ophthalmology and optic neuropathies. It begins by outlining the sites of potential lesions in the visual pathway, including the optic nerve, chiasm, and ocular motor nerves. It then covers the various etiologies of optic neuropathies such as inflammatory, ischemic, toxic, nutritional, hereditary, congenital, infiltrative and compressive causes. Specific conditions discussed in more detail include optic neuritis, anterior and posterior ischemic optic neuropathy, papilledema, pseudotumor cerebri and optic atrophy. For each condition, the document outlines clinical presentation, investigations, treatment and prognosis.
This document summarizes the clinical classification and investigations for uveitis. It divides uveitis into infectious and non-infectious categories. Infectious uveitis can be bacterial, viral, fungal or parasitic in origin. Non-infectious uveitis is further divided into those with a known systemic association and those without. Investigations may include blood tests, imaging like ultrasound and angiography, aqueous or vitreous taps, and biopsies depending on the severity, recurrence and presence of granulomatous signs. Specific tests are aimed at identifying underlying infectious or inflammatory diseases. A thorough history and examination provide important clues to guide appropriate investigations.
The document discusses various types of corneal diseases including congenital, traumatic, inflammatory, degenerative/dystrophic, and neoplastic conditions. It provides details on infectious keratitis caused by bacteria like Staphylococcus, Pseudomonas, and Neisseria as well as fungi and protozoa. Viral keratitis from herpes simplex virus, herpes zoster virus, and adenovirus are also examined. Signs, risk factors, investigations, and treatment approaches are described for each condition. Inflammatory keratitis can be infective or immune-related disorders like marginal keratitis and Mooren's ulcer are also reviewed.
A 19-year-old man presented with floaters and vision loss in his left eye over the past year. On examination, he had cells in his anterior chamber, vitreous hemorrhage, a swollen optic disc, cystoid macular edema, subretinal fibrosis, and chorioretinal scars in his left eye. Investigations did not reveal an infectious cause. He was treated with orbital floor triamcinolone injections which improved his cystoid macular edema but caused steroid-induced glaucoma, requiring glaucoma medication. His inflammation later flared up again requiring additional steroid treatment.
This document discusses uveitis, including its classification, description, causes, and clinical presentation. It provides details on:
1) The anatomical, pathological, and clinical classifications of uveitis including anterior, intermediate, posterior, and panuveitis.
2) The description of uveitis including its course (acute, recurrent, relapse, remission), duration (limited, persistent), and onset (sudden, insidious).
3) The common causes of different types of uveitis including infectious (viral, bacterial, fungal, parasitic) and non-infectious etiologies with and without systemic associations. Specific causes of anterior, intermediate, and posterior uveitis are
Uveitis is a general term for intraocular inflammation that does not indicate the specific site or cause of inflammation. It can be caused by autoimmune or infectious processes. Uveitis is a common cause of visual impairment and blindness worldwide. It is classified based on the site of inflammation - anterior, intermediate, posterior or panuveitis. Developing a differential diagnosis involves considering factors such as acuity of onset, laterality, associated symptoms and response to previous therapies. Common etiologies include idiopathic disease, infections like tuberculosis, and autoimmune diseases like sarcoidosis and Behcet's disease. Treatment involves corticosteroids and immunosuppressive therapies.
This document provides information on uveitis, including:
- Epidemiology data showing it is the third leading cause of blindness in developed countries, with highest rates in those over 65.
- Classification systems for uveitis based on location (anterior, intermediate, posterior, panuveitis) and duration (acute vs chronic).
- Signs and symptoms include redness, pain, photophobia, blurry vision, and floaters. Clinical signs depend on location and can include cells in the anterior chamber or snowballs in the vitreous.
- Differential diagnoses and specific types of non-infectious uveitis are discussed, including associations with autoimmune diseases like anky
This document provides an overview of the approach to diagnosing and treating posterior uveitis. It discusses the importance of a thorough clinical assessment to narrow the differential diagnosis and guide diagnostic testing. Common causes of posterior uveitis include infectious diseases like tuberculosis, toxoplasmosis, and viral infections, as well as non-infectious conditions like Behcet's disease, sarcoidosis, and VKH syndrome. Standard diagnostic tests include bloodwork, chest x-ray, fluorescein angiography, and OCT. Targeted testing depends on clinical features and may include vitreous biopsy and serologic testing. Characterization of the uveitis based on features like laterality, site of inflammation, and morphology
This document discusses various infectious causes of uveitis, including viruses, fungi, protozoa, helminths, and bacteria. It covers specific infectious etiologies such as herpesviridae family members, toxoplasmosis, toxocariasis, syphilis, Lyme disease, tuberculosis, and endogenous infectious endophthalmitis. For each condition, it describes clinical features, diagnostic testing, treatment approaches, and prognosis. Infectious uveitis remains an important consideration in uveitis evaluation and management.
This document provides information on diagnosing and treating various types of infective keratitis. It begins by emphasizing the importance of systematically describing any corneal lesion and differentiating infectious keratitis based on history and examination. The main types of infective keratitis discussed are bacterial, viral, fungal, amoebic, and non-infectious keratitis. For each type, the document describes distinguishing examination findings, investigations, and treatment approaches. It provides details on herpes simplex virus keratitis, including its various clinical manifestations and recommendations for long-term antiviral prophylaxis. The document also compares treatment for bacterial versus fungal versus amoebic keratitis. Throughout, it emphasizes the significance of early diagnosis
This document discusses different types of keratitis, including the differences between infective and non-infective keratitis. Non-infective keratitis includes marginal keratitis, phlyctenular keratitis, rosacea, peripheral ulcerative keratitis (PUK), Mooren's ulcer, and interstitial keratitis. PUK is associated with autoimmune diseases like rheumatoid arthritis. Mooren's ulcer presents as a peripheral, circumferential ulcer. Interstitial keratitis can be immune-mediated or infectious in etiology. The document provides details on clinical presentations, investigations, and treatments for different types of non-infective keratitis.
This document discusses various types of primary and secondary glaucomas including:
- Primary open angle glaucoma (POAG) which presents with increased intraocular pressure (IOP) and optic nerve damage in older patients.
- Primary angle closure glaucoma (PACG) which occurs when the iris blocks the drainage angle, commonly in East Asian populations.
- Normal tension glaucoma (NTG) which has optic nerve damage and visual field loss with normal IOP, often associated with nocturnal hypotension.
- Secondary glaucomas caused by conditions like pseudoexfoliation syndrome, pigment dispersion syndrome, neovascular glaucoma, and lens-induced glaucomas
This document summarizes a presentation on various eye conditions. It begins with a case of a 55-year-old woman with headache and blurry vision who is diagnosed with glaucoma. It then discusses the types, risk factors, examination, and management of glaucoma. It also covers hyphema, iritis, endophthalmitis, and compares the features of various red eye conditions like conjunctivitis. Interesting facts about eye anatomy and conditions are provided throughout.
This document summarizes different types of posterior uveitis and retinal vasculitis, including their causes, signs, symptoms, investigations, and treatment. It discusses various white dot syndromes such as multifocal choroiditis, birdshot choroidopathy, and acute macular neuroretinitis. It also covers specific conditions like toxoplasmosis, tuberculosis, frosted branch angiitis, and viral retinitis. Treatment often involves corticosteroids, immunosuppressants, antivirals, and laser photocoagulation depending on the underlying etiology.
This document discusses intermediate uveitis (IU), which involves inflammation in the anterior vitreous, pars plana, and peripheral retina. IU accounts for 8-22% of uveitis cases. Clinically, it is characterized by "snowballs" or yellow-white exudates in the peripheral vitreous. Treatment involves topical/periocular steroids initially, with cryotherapy, vitrectomy or immunosuppressants for non-responsive cases. Complications include cystoid macular edema, cataracts, glaucoma, and retinal detachment. Proper diagnosis requires excluding other causes like syphilis, Lyme disease, multiple sclerosis and sarcoidosis.
ACUTE AND CHRONIC CONDITION OF PHARYNX & LARYNX.pptDrBPSah
This document provides information about pharyngitis (inflammation of the pharynx). It discusses the different causes of pharyngitis including bacterial (e.g. Streptococcus pyogenes), viral (e.g. rhinovirus), and fungal. It provides details on symptoms, diagnosis, treatment, and complications of various types of pharyngitis. It also discusses other conditions that can cause pharyngeal inflammation like diphtheria, tuberculosis, and mononucleosis.
This document provides information about immunization and vaccine-preventable diseases. It discusses:
1. Immunization is a process that uses vaccines to stimulate immunity against infectious diseases. It has proven effective at controlling and eliminating diseases like smallpox.
2. Major vaccine-preventable diseases that kill children include measles, polio, pertussis, Hib, and pneumococcal diseases. Immunization is one of the most cost-effective health interventions.
3. The document then provides details on specific diseases like pertussis, its symptoms, complications, and treatment with antibiotics or immunization. It emphasizes the importance of clinical diagnosis and avoiding severe outcomes in infants.
This document discusses endophthalmitis, including its definition, classification, etiology, clinical presentation, diagnosis, and treatment approaches. It classifies endophthalmitis as infective or non-infective, exogenous or endogenous, and describes the most common causative agents. It provides details on clinical evaluation, diagnostic testing, medical and surgical management strategies, and prevention. It also summarizes key findings from the Endophthalmitis Vitrectomy Study regarding the role of vitrectomy and intravenous antibiotics in post-operative endophthalmitis.
i. Varicella, commonly known as chickenpox, is a highly contagious disease caused by the varicella zoster virus. It presents with a pruritic rash that starts on the scalp and face and spreads to other parts of the body, forming crops of lesions over successive days.
ii. Complications can include secondary bacterial infections if lesions are manipulated, and rarely pneumonia in severe cases or those who are immunocompromised. Vaccination with the live attenuated varicella vaccine provides protection against chickenpox.
This document provides information about immunization targets and diseases in Bangladesh. It discusses the leading causes of under-5 mortality globally and the disease burden of vaccine-preventable illnesses. The document lists the EPI target diseases in Bangladesh such as diphtheria, pertussis, tetanus, polio, Hib, measles, and pneumonia. It also discusses vaccines available in Bangladesh and those in the pipeline for future use. Details are provided about pertussis, diphtheria, and poliomyelitis including epidemiology, clinical features, complications, diagnosis and treatment.
This document provides information about immunization against various infectious diseases. It discusses the importance of immunization in preventing millions of deaths per year from diseases like measles, polio, diphtheria, and pertussis. The document outlines the target diseases for immunization programs in Bangladesh and other vaccines available in the country. It also discusses vaccines still in development and provides details on diseases like pertussis, diphtheria, and poliomyelitis, including causes, symptoms, treatment and complications.
A 15-month-old child presents with a fever and rash. The rash began as small red spots that have spread to other areas of the body over the past few days. The child also has a runny nose and cough. This presentation is consistent with measles, a highly contagious viral illness. A diagnosis of measles should be considered and appropriate isolation procedures followed given the contagious nature of the disease.
This document provides information on diphtheria, pertussis, and tetanus. It describes diphtheria as an infection caused by Corynebacterium diphtheriae that produces a toxin. Pertussis or whooping cough is caused by Bordetella pertussis bacteria and is characterized by severe coughing fits. Transmission of both diseases occurs through respiratory droplets. Vaccines exist to prevent diphtheria and pertussis. Treatment involves antitoxins for diphtheria and antibiotics to stop toxin production.
The document discusses various bacterial diseases categorized by pathogenic bacteria, symptoms caused, and mechanisms of infection. Key points include:
1) Common bacterial infections in children include those caused by Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae type b, which can cause pneumonia, meningitis, and other diseases.
2) Sexually transmitted diseases discussed are gonorrhea (caused by Neisseria gonorrhoeae), chancroid (Haemophilus ducreyi), granuloma inguinale, and syphilis (Treponema pallidum).
3) Enteropathogenic bacteria like Salmonella, Shigella,
This document summarizes information about various oral diseases including herpes simplex virus infections, oral candidiasis, deep fungal infections, precancerous lesions like leukoplakia and erythroplakia, oral cancer, and verrucous carcinoma. It describes the symptoms, causes, and characteristics of each condition. Recurrent herpes presents as small vesicles on the lips, gums, or palate that heal within a week, while oral cancer is often caused by tobacco or alcohol and has a low 5-year survival rate if detected late. The document also lists common sites of oral cancer and discusses molecular progression and metastasis.
This document contains information on evaluating and diagnosing various rashes and exanthems in children. It includes guidelines on taking a history regarding symptoms, exposures, and past medical history. It also provides details on examining the rash's morphology, distribution, and associated findings. Finally, it discusses evaluating and treating common rash-causing illnesses like measles, rubella, varicella, and dengue fever.
Mucormycosis ppt by Dr. Bomkar bam ENT M.S.Bomkar Bam
mucormycosis in the covid era in India. it is mostly seen in the post-recovery patient of covid - 19. most of the data are derived from the 2nd wave of covid in India.
This document summarizes clinical signs, diagnosis, and treatment for various diseases in cattle including diarrhea, wooden tongue, lumpy jaw, foot and mouth disease, and left displaced abomasum. For diarrhea, it provides a scheme for differential diagnosis based on temperature, fecal exam, and case history. Treatment depends on the identified cause and may include antibiotics, astringents, antidiarrheal medications, fluid therapy, or anthelmintics. Clinical signs, diagnosis, and treatment are also outlined for other diseases such as wooden tongue, lumpy jaw, foot and mouth disease, and left displaced abomasum.
This document provides information on routine immunization including the types of vaccines, how they work, and the diseases they protect against. It discusses vaccines for tuberculosis, polio, diphtheria, pertussis, tetanus, measles, hepatitis B, and MMR. It also covers key aspects of immunization like the cold chain, adverse events, contraindications, and surveillance. The overall message is that immunization is one of the most cost-effective health interventions and a child's right to protect them from vaccine-preventable diseases.
seminar briefly covers the oral findings and treatment related to hsv virus like erythema multiforme, SJS, Varicella zoster, epstein barr virus, infectious mononucleosis
This document provides information about pertussis (whooping cough). It discusses the causative bacteria, Bordetella pertussis, and describes the typical three stages of the disease - catarrhal, paroxysmal, and convalescent. It notes the disease is highly contagious and a major killer of infants. Complications in infants can include pneumonia, seizures, and death. Diagnosis is usually clinical based on symptoms, and confirmed with lab tests. Antibiotics are the treatment of choice and aim to shorten the illness and prevent spread. Immunization provides protection but does not prevent all cases of pertussis.
This document summarizes meningitis in children, including the definition, causes, signs and symptoms, diagnosis, treatment, and prevention. Meningitis is an inflammation of the membranes surrounding the brain and spinal cord. It most commonly affects infants and children under 5 years old. Bacteria such as pneumococcus, meningococcus, and H. influenzae are common causes. Signs include fever, headache, neck stiffness, and altered mental status. Diagnosis involves lumbar puncture and culture of spinal fluid. Treatment involves antibiotics and supportive care. Vaccines can help prevent certain bacterial types. Complications may include neurological deficits if not treated promptly.
This document discusses choroiditis, an inflammation of the choroid layer of the eye. It begins by introducing choroiditis and classifying it anatomically and by etiology. It then discusses infectious causes such as parasites, bacteria, viruses, and fungi. Non-infectious causes are also listed. The document outlines symptoms, signs, and characteristics of choroiditis lesions. Specific sections provide details on toxoplasmosis and toxocariasis, two common causes of choroiditis. Treatment options including medications, surgery, and procedures are mentioned. In summary, the document provides a comprehensive overview of choroiditis, including causes, presentation, diagnosis, and management.
This document discusses diphtheria, an infectious disease caused by the bacteria Corynebacterium diphtheriae. It produces an exotoxin that can cause local infection in the throat and airways and lead to complications affecting the heart, kidneys and nerves if the toxin spreads systemically. Clinical manifestations depend on the site of infection and may include pseudomembrane formation. Diagnosis involves culture, microscopy and toxin testing. Treatment is with antitoxin to neutralize the toxin as well as antibiotics. Active immunization with diphtheria, tetanus and pertussis vaccine (DwPT or TdaP) provides protection.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Adhd Medication Shortage Uk - trinexpharmacy.comreignlana06
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
ABDOMINAL TRAUMA in pediatrics part one.drhasanrajab
Abdominal trauma in pediatrics refers to injuries or damage to the abdominal organs in children. It can occur due to various causes such as falls, motor vehicle accidents, sports-related injuries, and physical abuse. Children are more vulnerable to abdominal trauma due to their unique anatomical and physiological characteristics. Signs and symptoms include abdominal pain, tenderness, distension, vomiting, and signs of shock. Diagnosis involves physical examination, imaging studies, and laboratory tests. Management depends on the severity and may involve conservative treatment or surgical intervention. Prevention is crucial in reducing the incidence of abdominal trauma in children.
12. Endogenous fungal EFE
– Candida
• <AIDS related, candidaemia (IV/cathether/lung)
• AU (+-granulomatous)
• IU (cotton ball/string of pearls/abscess)
• PU (chorioretinitis → necrosis/ERD/PVR)
– Aspergilus
• >AIDS related, >endocarditis
• AU + IU + PU (>macula/>vaso occlussion/>rapid)
– Rx:
• IV: Ampho B
• PO: Vorico, Fluco, Itra, Imida
• IVT: AmphoB 5-10ug/0.1ml, Vorico, Mico 0.01mg/0.1ml
• early TPPV for mod-severe ifx
13. Exogenous Endoph- Mx
1. Prevention & Prophylaxis
• Pre op: risk identify (ocular/systemic/op) & Mx
(immune/autoimmune/lid/mental)
• Ocular: Surface/adnexal (lid/tear/conj/NLD)
• Systemic: Immuno/DM/steroid
• Operation: Type (glaucoma op/2nd IOL/ICCE > ECCE > phaco),
Complicated/long duration, Wound/suture (clear cornea > scleral
tunnel, IOL type (silicone > PMMA > acrylic), OT contamination/high
temperature
• Intra op: povidone 5% or chlorhexidine 0.05%/eyelashes/
wound/intracameral Ab cefuroxime 1mg/0.1ml
2. Identification & Mx
• Post op: triad (hypopyon/pain red/BOV), tap & inject, prognosis 50% VA
> 6/12
3. Surgical Management
• Acute (<6wk) + VA worse than HM (EVS) or opaque media/not
responding to IVT AB (CEVE) TPPV/IVT AB/KIV membrane peel at AC/angle
• Chronic (>6wk/P.Acne capsular plaque) TPPV/partial post capsulectomy/ IVT AB
into capsular bag/KIV total capsulectomy with IOL exchange)
• Bleb-associated (mth/yr with blebitis) >virulent/poor outcome
14. Post op & Endogenous Endoph- Mx
• Endogenous bacterial
– Vision <HM TPPV, >/=HM tap & inject + early VR referral
– Rx (IVT): vancomycin 2mg/0.1ml for gram+ & cephalosporin ceftazidime
2mg/0.1ml or aminoglycoside/amikacin 0.4mg/0.1ml (if allergic to penicillin) for
gram- rod repeat aft 48H for TPPV if still not response
– Rx (oral): Ciprofloxacin 750mg BD x 14/7, T. Moxifloxacin 400mg OD x 10/7, or T.
Clarithromycin 500mg BD x 14/7 (added on Cipro, biofilm reduction, for culture –
ve case)
– Rx (topical Ab): fortum 5% + vanco 5%/genta 0.9% (>post op exoG )
– Rx (topical steroid): pred forte/maxidex 1% 2hourly right aft tap/inject
– Rx (IVT steroid): IVT Dexa 0.4mg/0.1ml if responded to antibacterial, not for
fungal
– Rx (oral steroid): +- oral steroid 1mg/kg/day aft 24H of AB, taper 10mg/wk, total
duration 3wk, not for fungal
– Rx (TPPV/AC wash out/IVT): for VA PL or worse, severe vitritis/opaque media
?Dx, not response to 2x IVT in 48H, mod-severe fungal endoph
– Others
• Subconjunctival A/B. mydriacaine
15. Common Organisms in Endophthalmitis
• In acute-onset postoperative endophthalmitis, the most common organisms are coagulase-
negative Staphylococci, followed by Staphylococcus aureus and Streptococci. In India, fungal
endophthalmitis is relatively more common (about 20% of cases) than bacterial endophthalmitis. In
delayed-onset (chronic) postoperative endophthalmitis, the most common organism
is Propionobacterium acnes, followed by fungi. In early-onset bleb-associated endophthalmitis, the
most common organisms are coagulase-negative Staphylococci and S. aureus. In delayed-onset
bleb-associated endophthalmitis, the most common organisms are streptococci and Gram-negative
organisms, including Moraxella catarrhalis. In endophthalmitis following intravitreal injection, the
most common causal organisms are coagulase-negative Staphylococci, followed
by Streptococci, Bacillus cereus, Enterococcus faecalis, and others. Overall, Streptococci and other
oral flora are relatively more common in these patients than in postoperative patients. In post-
traumatic endophthalmitis, the most common organisms are coagulase-
negative Staphylococci, Streptococci, and Bacillus. In endogenous endophthalmitis, the most
common organisms vary by geographic location, but overall fungi are more common than bacteria.
Common fungal pathogens include Candida albicans and Aspergillus. In the USA and Europe,
common bacterial pathogens include Gram-positive organisms, but in East Asia, Gram-negative
organisms (including Klebsiella) predominate
• The best outcomes usually occur in cases that are either culture-negative or are caused by
coagulase-negative staphylococci, and the worst outcomes typically occur in endophthalmitis
caused by streptococci, Bacillus species, and moulds
16.
17. Strep Endophthalmitis
• Streptococcus intermedius, a type of viridans
streptococcus typically associated with head and neck
abscesses
• Streptococcus constellatus is generally a commensal
organism found in the mouth, oropharynx, dental work
and gastrointestinal tract.
• Strep EBE- endocarditis, septic arthitis, poor outcome
• vanco fortum levofloxacin
• strep pneumonia, GBS (agalactiae), Strep viridans,
18. • Intravitreal corticosteroid may be given at the
discretion of the surgeon, dexamethasone 400
micrograms in 0.1 ml* or triamcinolone
acetonide 4 mg in 0.1 ml*
• This should only be considered once the
infection (both systemic and ocular) is deemed to
be under control and after liaison with the
physicians. Use prednisolone 500 micrograms to
1 mg/kg/day in conjunction with an H2-
antagonist (ranitidine), or proton-pump inhibitor
(lansoprazole).
19. Chorioretinitis in infants- DDX
• congenital infections TORCHES
• congenital anomalies
• congenital hypertrophy of RPE
32. HIV/AIDS
h transmission/stages of dz/AIDS
h HIV ifx/opportunistic ifx/malignancy
h Eye problem 75%
Intraocular Orbital CNS Systemic
PanU
•AU: drug (cidofovir/rifabutin), ifx
•IU/PU: ifx CMV, PORN >ARN (HSV/HZV),
toxoplasmosis, fungal & POHS/TB/syphilis
(>ASPPC), lymphoma
• HIV retinopathy (70%): RVO-like >post
pole, related to CD4/RNA load, no
Sx/BL/multiple/transient
• Eyelid: ifx,
HZO Kaposi,
molluscum
contagiosum
•ulcerative
blepharitis
• HIV
encephalopathy
• ONeuritis
• acute/sero-
conversion
• latent/PGL
External:
• Conj ifx, Kaposi/SCC/microvasculopathy
• Cornea ifx, KCS
• Orbit: ifx,
lymphoma
• CNS ifx
• CNS neoplasm
(lymhoma)
•CNP
• AIDS
❖ Ix (systemic): CD4, plasma RNA, HepB/C/TB/syphilis
❖ Ix (ocular):
❖ Rx: HAART
33. CD4 in HIV vs Eye
• CD4+ <500/µL: Kaposi sarcoma, lymphoma, and
tuberculosis.
• CD4+ <250/µL: pneumocystosis and toxoplasmosis
• CD4+ <100/µL:
– Retinal or conjunctival microvasculopathy
– Cytomegalovirus (CMV) retinitis
– Varicella-zoster virus (VZV) retinitis
– Mycobacterium avium complex infection
– Cryptococcosis
– Microsporidiosis
– HIV encephalopathy
– Progressive multifocal leukoencephalopathy
34. CMV
h PU= AIDS defining (CMV retinitis)- CD4 <50, natural history 5R
h AU= immuno-good pt (+- a/w FHU/Posschner SS)
Intraocular Systemic
• AU: like HSV/HZV (+failed aciclovir)
• IU: mild (except IRU)
•PU (3 forms & 3 zones I-III: 2DD fovea+1DD OD-till equator-rest)
-Fulminant/classical (hrge): pizza pie/cheese & ketchup along
arcade >central > necrosis
-Indolent (granular): periphery (90%), less
aggressive/inflam/vasculitis
• no Sx in immuno-
competent
• CNS
• Lung
• Skin
-Frosted branch angiitis 6% (++sheathing)
• Cx: OD/CMO/vasculitis/retinal necrosis (atrophy/hole/RD 50%)
• congenital: cataract/microphthal/PU/OD
• CMV keratitis (>endothelitis)
• Congenital: intracranial
calcification, mental,
deaf, microcephaly,
jaundice/HSM,
❖ Ix (systemic): CD4/RNA load (HIV status)
❖ Ix (ocular): vitreous PCR
❖ Rx: HAART vs IRU, aim CD4 100-150 for 3-4mth,
❖ Rx: oral valganciclovir 900mg BD 3-6wk then OD (SE- BMS, need GCSF/filgrastim),
GanC (IV 5mg/kg BD 2wk then OD/IVT 2mg/0.1ml biweekly x 3wk then weekly/IVT implant
8mth), foscarnet (IV/oral/IVT, SE renal, IV foscanet 90mg/kg BD 2wk then OD), cidofovir
(IV/oral weekly then fortnightly, SE renal), steroid if IRU, laser if break (no role for prophylactic)
❖ screen: CD4 <50 (q3mth), 50-100 (q6mth), >100 (yearly)
35. CMV Lab test
• Congenital CMV
–+ve culture before age 3 wk
–If aft 3wk can be perinatally acquired ifx or
breast milk acquisition
– symptomatic vs asymptomatic
– IgM: non specific & high false +ve
36. HZV
- Direct invasion chicken pox dormant @dorsal root of CN sensory ganglia shingles
- 2nd inflammation causing stromal K/vasculitis/uveitis/scleritis
Intraocular Systemic
• Congenital: cataract/microphthal/OD
• Keratitis- reduced sensation + epiT (dendrite/taper)/
stroma (numular/interstitial)/endoT (disciform)/AU
• Scleritis: most! +-necrotizing
• AU: fine KPs, iris atrophy, high IOP, recur!
• Skin HZO shingles –
complete dermatome, never
BL (Hutchinson’s sign)
• Cx: post herpetic neuralgia
• PORN (immuno-down/aggressive BUT min AU/IU/vasculitis
(vessel sparing)/inflam/hge!)- 3stages: early macula retinitis
(cherry red spot), middle necrosis, late scar (cracked
mud)/RD/OD atrophy
• ARN (old pt/immuno-good): >panU/inflam/vasculitis
>artery/hrge/well margin retinitis fr periphery (vs PORN)-
4stages: retinitis-vitritis-pigment change-RD/OD atrophy)
• HZO without dermatitis =
zoster sine herpete
• Chickenpox- eye involved if
immuno-down
• Congenital- mental,
limb/skin deform, death
❖Ix (ocular): tap for viral PCR
❖Rx (corneal epiT): occ aciclovir 3% 5x/day (or oral to avoid toxicity)
❖ Rx (stromal K): gutt steroid (watch ED) + topical aciclovir/oral BD dose (prophylaxis)
❖ Rx (AU): T Aciclovir 800mg 5x/day x 1wk (T valA 1g TDS), Gutt steroid, KIV prophylaxis
❖ Rx (PORN/ARN): IV aciclovir 10mg/kg TDS 2wk, IV/IVT GanC/Foscarnet + HAART + steroid
❖ HZO: T aciclovir start within 72H reduce severity/eye involve 50%/neuralgia
37. HSV
HSV1/2 (above/below waist), primary ifx (very common-by contact/virus shed) → dormant @
axon/ganglion (latent) recurrence/reactivation + 2nd inflam
Intraocular Systemic
•Lid/Conj: vesicular blepharoconj/follicular conj
•Keratitis: reduced sensation, epiT dendritic/bulb K (stain edge
RB/central F), stromal K (IK/DK/+-necrotizing), endotheliitis
• Corneal late Cx: neurotrophic/metaherpetic/bullous/lipid K/scar
• AU: diffuse fine KPs, iris atrophy (sectoral), high IOP, recur!
• Primary/reactivation
- skin CN V (incomplete
dermatome)
- cold sore
• genital
• ARN (young pt/immuno-good/w encephalitis/skin HSV)- 5 criteria:
PanU, retinitis (peripheral/well margin/2-3mth to necrosis),
peripheral to center, occlusive vasculitis (A), rapid progress.
• neonate (fr genital
tract)- skin/MM/
encephalitis
❖ Rx (EpiT K): topical aciclovir 5x/topical trifluridine 1% 8x/oral aciclovir 400mg 5x for 2/52
❖ Rx (stromal K ): topical trifluridine 8x/oral aciclovir 400mg BD + gutt steroid 2H taper wkly KIV prophylx
❖ Rx (AU): T Aciclovir 400mg 5x/day (FamC 250mg TDS/ValA 1g BD better) + gutt steroid KIV prophylx
❖ Rx (ARN): IV Aciclovir 10mg/kg TDS x 2wk then oral 800mg 5x/day for 2-3mth, IVT GanC/foscarnet,
steroid (24H aft), laser retinopexy, aspirin
❖ Rx (prophylaxis-recurrence/post PK): 400mg BD for 12mth (recurrence less 50%)
42. AntiTB
• Intensive+Maintenance
• EHRZ/Akurit-4 (2mth) + HR/Akurit (4-7mth)
• TB workup/DOTS/baseline LFT/FBC/eye
• Isoniazid (5mg/kg max 300mg OD): skin/liver/anemia/ON
peripheral neuropathy (need pyridoxine B6)
• Rifampicin (10mg/kg max 600mg OD): skin/liver/warfarin
less effect/pink fluid/tear/ON
• Ethambutol (15mg/kg max 1200mg): ON/jt/liver/peripheral
neuropathy
• Pyrazinamide (20mg/kg max 1500mg OD): liver/joint
• Streptomycin (15mg/kg max 1g OD): better penetrate BBB,
SE renal/oto/GI
• Akurit-4: 38-54kg (2-3-4 tab OD)
43. TB- extra
• PTB 80% vs extrapul TB 20%
• PTB: 90% no Sx, 50% N CXR, 20% -ve PPD
• NTM: >HIV/less virulence/more Rx resistant
• HIV: >MDR/atypical/extrapul/miliary TB
• Tine test @paeds (vs PPD)
• Quantiferon vs PPD: IF-gamma (IGRA), less
affected by BCG/more specific/sensi same
• Other test: TB spot (IGRA), PCR, GeneXpert
(Tawakal/Prince court)/LPA/Adenosine
deaminase (Gribbles)
44. Syphilis (Treponema Pallidum)
h eye involvement more in 2nd/3rd syphilis
Intraocular Orbital CNS Systemic
PanU (granulomatous)
• AU (4%): roseolae (dilated iris
capillary/yellow nodule)/iristis
roseate-papulosa-nodosa
- PU: chorioretinitis/vitiris/retinitis
(ground glass)/vasculitis (V&A,
occlusive), OD neuritis
- Acute syphilitic posterior placoid
chorioretinopathy (ASPPC)- yellow/
subretinal/RPE ifx in immuno-low pt)
• dacryo-
cystitis/-
adenitis
• cellulitis
•Argyll
Robertso
n
• CNP
• ON
• tonic
pupil
• Horner
•Primary- genitalia/anus
chancre (painless), LN
•Secondary- rash/condyloma
•Tertiary- CVS (AR/aortitis),
CNS (neurosyphilis/paresis/
tabes dorsalis), gumma
(tongue/bone /visceral)
Ext eye
• Scleritis/ES/conj/conj chancre/IK!
• Congenital: IK (5-25yo! KU, sublux
len/ cataract, salt&pepper fundus.
ARP
• madarosis •Latent
•Congenital- stillbirth, lips
rhagades, deaf, bull-dog jaw,
Hutchinson teeth, Clutton jt,
saddle nose, sabre tibia
❖ Ix (systemic): VDRL/RPR → TPHA (vs prozone), HIV, CSF VDRL/cyto/dark field (neurosyphilis)
❖ Ix (ocular): Aq/vitreous tap for PCR
❖ Rx: IV penicillin G 2-4megaU 4Hly (24mU/day) x 2wk, or IM 2.4 megaU weekly x 3wk (watch
out Jarisch–Herxheimer), steroid (topical/systemic) *penicillin allergy EES/doxy
45. Syphilis Serology
• Treponemal antibody tests (TPHA/FTA-ABS/ELISA)
– are highly sensitive and specific, but take around 3
months to become positive.
– Prozone phenomenon (too high Ag with false –ve →
need dilution then +ve)
• Rapid plasma reagin (RPR) or venereal disease
research laboratory (VDRL)
– Non-specific titratable cardiolipin antibody tests
– for screening + monitoring
• +ve in early infection → negative over time/treated
– False-positive (RA/pregnancy/leprosy/mononucleosis)
– False-negative (HZV/3rd syphilis/Prozone)
46. Cat Scratch/Bartonellosis
h Bartonella henselae, a Gram-negative rod
h = benign lymphoreticulosis
h cat (healthy) scratch/bite skin LN eye (2wk)
Intraocular Orbital CNS Systemic
• Neuroretinitis! (most/60%)-
macular star + OD edema
• IU/focal retinochoroiditis/
vasculitis
• Inoculation
site papule,
• Conjunctivitis 2–4 mm granuloma
(Parinaud oculoglandular syndrome
+ auricular LN DDX TB)
• fever, LN
(regional)
❖ Ix (systemic): serology
❖ Rx: Oral co-trimoxazole, azithromycin, rifampicin or doxy/ciprofloxacin (avoided in
children)
47. Lyme/Borreliosis
h Tick borne (Ixodes)/deer/Borrelia burgdorferi (spirochete) → 3 stages
h Eye: stage 1 → 3 (ant → post → ant)
Intraocular Orbital CNS Systemic
• External
• F-follicular conj (stage 1)
• Scleritis/EpiS (nodular)/
Interstitial-stromal K (stage 3)
• Orbital
myositis
(stage 3)
• CNP
(EOM/7th)
• Meningitis
Stage 1 (local)
- Skin: erythema chronicum
migrans (annular) + flu-like
• Uveitis- rare (stage 2)
• IU: most
• AU: rare, +-granulomatous
- PU: neuroretinitis/
choroiditis/vasculitis
• O neuritis
• Papilloedema
Stage 2 (disseminate)
- CNS: menig/encephalitis,
polyneuropathy
- CVS- arrhythmia
Stage 3 (immune-related)
- MSk- arthritis
❖ Ix (systemic): serology (incubation 1/12), CSF/synovial fluid
❖ Ix (ocular):
❖ Rx: oral doxy/augmentin/EES or IV ceftriaxone/penicillin + steroid
48. Brucellosis
h Gram-negative bacteria Brucella melitensis and B. abortus
h through milk products or uncooked meat
Intraocular Orbital CNS Systemic
• chronic AU/PU
• papilloedema
• retinal haemorrhages
❖ Ix (systemic):
❖ Ix (ocular):
❖ Rx: streptomycin + doxycycline, +- steroids
49. Leprosy
- Mycobacterium leprae/lepromatosis
- MOT: unsure/contact/nasal secretion/genetic
Intraocular Orbital CNS Systemic
• CAU: plasmoid/fibrin++/PS
• Iris: pearl (<0.5mm),
atrophy, nodular iris
lepromas
• Pupil: miosis, anisocoria
• Retina: pearl
• Eyelid
deform/
madarosis
• 7th
CNP
• ON
• abn
pupil
• peripheral neuropathy! (loss of digits)
• Keratitis: prominent nerve,
interstitial K, neuropathy K,
pannus/scar
• Scleritis/ES
• dacryo-
cystitis/
NLDO
• Tuberculoid (pauci-bacillary)- skin
anesthetic/macular hypoP patch
• Borderline (multiB)- skin ++
• Lepromatous (multiB)- leonine facies
(skin thickening/plaque/nodule), URT
❖ Ix (systemic): skin/sural nerve biopsy (AFB), Lepromin test for cell medicated immunity for
tubercoloid leprosy- Fernandez @48H, Mitsuda @4wk)
❖ Ix (ocular):
❖ Rx: oral dapsone, rifampicin and clofazimine, +- steroid
50. Bacteria- Others
• Chlamydia (trachomatis > psittaci/pneumoniae)
– STD/GN/intracellular IX Giemsa/IF/PCR
– Trachoma (A/B/C): acute vs cicatricial, WHO 5stages (F-I-S-T-
CO)/Herbert pits/Arlt line
– inclusion conj (D-K) @adult/neonate
– Mx: SAFE, topical tetracycline + oral Azithromycin 1g stat/7D (2g if
N gonorrhea co ifx)
• Leptospirosis (interrogans)
– Spirochete/GN/rodent/systemic vasculitis/systemic non
icteric/icteric-Weil dz
– Conjunctival congestion D3-4 uveitis @immune phase >panU
– Mx: doxycycline 100mg BD/IV penicillin 1.5megaU QID/IV
Rocephine x 1wk +topical steroid
52. Candida (C. Albicans)
h risk: immunosuppresed but not commonly related to AIDS
Intraocular Orbital CNS Systemic
• Keratitis
Endophthalmitis (endoG >exoG)/PanU
(>BL >slow progress)
• AU (+-granulomatous >mild)
• IU (cotton ball/string of pearls/abscess)
• PU- chorioretinitis (creamy white/1 or
multiple) → necrosis/ERD/PVR)
• sepsis/candidaemia
(IV/cathether/lung)
- If untreated 1/3
to eye
❖ Ix (systemic): source (urine/blood/sputum)
❖ Ix (ocular): vitreous biopsy/tap
❖ Rx: antifungal (ampho B/-conazole)- IV/oral/IVT, TPPV
53. Histoplasmosis/POHS (H. capsulatum)
h dimorphic (yeast for inhalation)
h AIDS related, HLA B7/DR2 related!, endemic @ US
h eye: > asymptomatic granulomatous choroiditis d2 immune response!
Intraocular Orbital CNS Systemic
Immune response granulomatous
choroiditis:-
• Triad: histo spot (200um/white-dot-
like/pigment) + PPA + no IU/AU/inflam!
• Location: linear scar @midperipheral
periOD, post pole
• Lung!
• Liver
• Spleen
CX
• CNV or ERD!! (late)- near histo spot
❖ Ix (systemic): serology, HLA B7/DRW2, skin Ag test (out!)
❖ Ix (ocular): FFA/OCT (CNV)
❖ Rx: CNV (antiVEGF/PDT/Argon)
54. Fungal: Others
• Pneumocystis choroiditis
– P. jirovecii (AIDS defining, lung)
– Choroiditis: BL multiple/slow progress, min IU
• Cryptococcal choroiditis
– C. neoformans (AIDS/pigeon exposure, CNS/lung, meningitis/OD/EOM!)
– Choroid-retinitis: multifocal/necrotizing/vasculitis/exudate
• Aspergillus endophthamitis
– AIDS/immuno-down (a/w endocarditis)
– AU + IU + PU (>macula/>vaso occlussion/>rapid)
– Orbit: fulminant/chronic/allergic sinusitic
• Coccidioidomycosis
– C. imitis (lung/meningitis)
– choroiditis (multifocal) + AU (granulomatous)
– +- Parinaud oculoglandular syndrome (DDx cat scratch/TB)
• Pneumocystic choroiditis (P. jirovevii/AIDS)
• Mucor/Rhizopus- orbital zygo-/Mucor-mycosis
55. Antifungal: the challenge
• lower efficacy due to their mechanism of
action (usually fungistatic, with fungicidal
action being dose dependent)
• lower tissue penetration
• indolent nature of the infection
• Possible antagonistic effect btw azole-
polyene: azole decreases synthesis of
ergosterol at cell membrane- binding site for
polyenes action
56. Ampho B
• Topical 0.15-0.5%
• Intrastromal 5 to 10 ìg interval 7days
• Intracameral 5 to 10 ìg/0.1ml interval 24H
• Intravitreal 1 to 10 ì g/0.1ml interval 3days
(longer for non-vitrectomised eye)
• 10ug/0.1ml = 100ug/ml (0.1%) compared
to vorizonazole 50ug/0.1ml = 0.5%
57. Azole
• Topical
– Miconazole 1%
– Ketoconazole 1-5%
– Itraconazole 1%
– Fluconazole 0.2%
– Voriconazole 1-2% self prepared stable for 28days
• Intracameral
– Voriconazole 50ug/0.1ml (500ug/1ml = 0.05%)
• Subconjunctival
– Miconazole 1.2 to 10 mg
– Fluconazole 2 mg in 1 ml OD x 10/7, EOD till remission
– Subconjunctival voriconazole 10mg in 1ml (1%)
• Intrastromal
– Voriconazole 50 ug/0.1 ml
• Oral
– Ketoconazole 100-400mg BD (200mg BD)
– Itrazonazole 400mg per day (100mg BD)
– Fluzonazole 200-400mg per day (100mg BD)
– Voriconazole 400mg BD day1 then 200mg BD
• Intravitreal
– Voriconazle 10-50ug/0.1ml